EGRX
Eagle Pharmaceuticals Inc
Price:  
5.87 
USD
Volume:  
49,339.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX WACC - Weighted Average Cost of Capital

The WACC of Eagle Pharmaceuticals Inc (EGRX) is 7.7%.

The Cost of Equity of Eagle Pharmaceuticals Inc (EGRX) is 11.65%.
The Cost of Debt of Eagle Pharmaceuticals Inc (EGRX) is 5.05%.

Range Selected
Cost of equity 10.10% - 13.20% 11.65%
Tax rate 39.20% - 44.10% 41.65%
Cost of debt 4.70% - 5.40% 5.05%
WACC 6.8% - 8.6% 7.7%
WACC

EGRX WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.35 1.48
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.10% 13.20%
Tax rate 39.20% 44.10%
Debt/Equity ratio 0.82 0.82
Cost of debt 4.70% 5.40%
After-tax WACC 6.8% 8.6%
Selected WACC 7.7%